Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuralgia × Hydromorphone × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 7 Cancer Pain 3 Uterine Cervical Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Postoperative Complications 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasms 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1 Intraoperative Complications 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Emergencies 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Acute Pain 1

Interventions

Lidocaine 4 Oxycodone 2 ziconotide 1 nabiximols 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Magnetic Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Surveys and Questionnaires 1 Sodium Chloride 1 Pregabalin 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hypnosis 1 Hydromorphone 1 Geritol 1 Gabapentin 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡